Plexus Corp (PLXS) 43.52 $PLXS
Plexus Q2 Earnings in Line, Revs Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 10:40AM CDT
Plexus reported a better-than-expected second-quarter fiscal 2014
Plexus Corp. Reports Second Quarter Results
Thomson Reuters ONE - Wed Apr 16, 3:00PM CDT
April 16, 2014
Financial Release Schedule -- Research on Abbott Laboratories, PNC, American Express, and Plexus
PR Newswire - Wed Apr 09, 9:58AM CDT
Earnings Source provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Abbott Laboratories (NYSE: ABT), The PNC Financial Services Group Inc. (NYSE: PNC), American Express Company (NYSE: AXP) and Plexus Corporation (NASDAQ: PLXS). Full earnings notes on ABT, PNC, AXP and PLXS can be downloaded upon signing up at:
Plexus Corp. Fiscal Second Quarter 2014 Earnings Date Set
Thomson Reuters ONE - Wed Mar 05, 3:00PM CST
March 5, 2014
Upgrade Alert for Plexus (PLXS)
Comtex SmarTrend(R) - Mon Feb 24, 7:09AM CST
Plexus (NASDAQ
LXS) was upgraded from Underperform to Market Perform at Raymond James today. The stock closed yesterday at $40.42 on volume of 228,000 shares, above average daily volume of 210,000. Plexus Corp. is a participant in the Electronics Manufacturing Services (EMS) Industry, providing product design,supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure,Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.
Plexus Donates Money for New Equipment at Appleton East's Tesla Engineering Charter School
Thomson Reuters ONE - Wed Feb 12, 8:30AM CST
February 12, 2014
Plexus Reports In-line Q1 Earnings; Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 8:20AM CST
Plexus reported a weak first-quarter fiscal 2014, as earnings of 61 cents per share were in line with the Zacks Consensus Estimate but revenues missed the same
Plexus Corp. Reports First Quarter Results
Thomson Reuters ONE - Wed Jan 15, 3:00PM CST
January 15, 2014
Plexus Has Returned 57.6% Since SmarTrend Recommendation (PLXS)
Comtex SmarTrend(R) - Tue Jan 14, 9:23AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ LXS) on January 2nd, 2013 at $26.50. In approximately 13 months, Plexus has returned 57.62% as of today's recent price of $41.77.
Is Plexus (PLXS) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 8:30AM CST
Plexus Corp is set to report fiscal first-quarter 2014 results on Jan 15
Downgrade Alert for Plexus (PLXS)
Comtex SmarTrend(R) - Tue Jan 14, 7:00AM CST
Plexus (NASDAQ LXS) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $41.64 on volume of 300,000 shares, above average daily volume of 157,000. Plexus Corp. is a participant in the Electronics Manufacturing Services (EMS) Industry, providing product design,supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure,Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.
5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Jan 13, 12:56PM CST
These heavily shorted stocks could get squeezed much higher this week if they report positive earnings.
Form 144: Filing to Sell 89760 Shares of Fidelity Natl Information Se (FIS)
Vickers Stock Research - Tue Jan 07, 4:20AM CST
PLEXUS UPDATES FISCAL FIRST QUARTER REVENUE AND EARNINGS OUTLOOK
Plexus Up 59.6% Since SmarTrend Uptrend Call (PLXS)
Comtex SmarTrend(R) - Mon Jan 06, 4:40PM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 59.58% as of today's recent price of $42.29.
Global Medical Device Manufacturing Services Outsourcing Market 2014-2018: Top 4 Dominant Players Analysed
M2 - Mon Jan 06, 11:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/3h8mj7/global_medical) has announced the addition of the "Global Medical Device Manufacturing Services Outsourcing Market 2014-2018" report to their offering. The analysts forecast the Global Medical Device Manufacturing Services Outsourcing market to grow at a CAGR of 11.86 percent over the period 2013-2018. One of the key factors contributing to this market growth is the advancement in healthcare technologies. The Global Medical Device Manufacturing Services Outsourcing market has also been witnessing the outsourcing to emerging countries. However, the stringent regulatory guidelines could pose a challenge to the growth of this market. The key vendors dominating this market space are Accellent Inc., Creganna-Tactx Medical, Greatbatch Inc., and Flextronics International Ltd. Other vendors mentioned in the report are Cadence Inc., Celestica Inc., Nortech Systems Inc., Plexus Corp., WuXiAppTec Co. Ltd., CIRTEC Medical Systems LLC, and Micro Systems Technologies Management AG. Commenting on the report, an analyst from the team said: Outsourcing of medical device manufacturing services to emerging countries is a growing trend in the market. By outsourcing, leading medical devices companies not only take advantage of reduced costs but also position themselves to better serve the local markets of emerging countries. Reduced cost of labor, a high level of technical expertise, and funding from governments for R&D investment to accelerate new product development in emerging countries such as China, India, Malaysia, Mexico, and Brazil have made them the most favored destinations for outsourcing manufacturing services. Hence, outsourcing to emerging countries is expected to drive the Global Medical Device Manufacturing Services Outsourcing market during the forecast period. Further, the report states that one of the major challenges in the market is stringent regulatory guidelines that need to be adhered to by outsourcing services providers for quality control and meet environmental requirements. For more information visit http://www.researchandmarkets.com/research/3h...al_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Plexus Shares Up 61.3% Since SmarTrend's Buy Recommendation (PLXS)
Comtex SmarTrend(R) - Mon Dec 30, 9:13AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 61.32% as of today's recent price of $42.75.
Plexus Up 60.4% Since SmarTrend Uptrend Call (PLXS)
Comtex SmarTrend(R) - Fri Dec 20, 4:54PM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 60.42% as of today's recent price of $42.51.
Global Medical Device Outsourcing Market Report 2013
M2 - Tue Dec 17, 6:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/w8px76/medical_device#summary) has announced the addition of the "Global Medical Device Outsourcing Market Report 2013" report to their offering. "Global Medical Device Outsourcing Market Report 2013", provides insights into global markets for Medical Device Outsourcing in US$ Million by the following Device Categories: Class I, Class II, and Class III. The application areas also analyzed in the report include: - Radiology - Orthopedic - Neurology - Cardiology Another addition to this research analysis is the separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 80 companies including many key and niche players such as Accellent Inc., Advanced Scientifics Inc., Aptiv Solutions, Benchmark Electronics, Inc., Cadence, Inc, Code Refinery LLC, CregannaTactx Medical, Celestica HealthTECH, EtQ, Inc., Flextronics International, Greatbatch, Inc., HCLs Life Science, Innovative Medical Device Solutions, Intertech Engineering Associates Inc., Lake Region Medical, Memry Corporation, Millstone Medical Outsourcing, LLC, Minnetronix, Inc., Nortech Systems Inc., Plexus Corporation, Providien, RTEmd, Symmetry Medical Inc., The Tech Group, Inc., Vention Medical, Venture Manufacturing Group, Inc., and WuXiAppTec Co. Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions - Study Reliability And Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions And Scope Of Study - Device Category - Application Area II. Executive Summary 1. Industry Overview 2. Product Overview 3. Recent Industry Activity 4. Focus On Select Global Players 5. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 80 (including Divisions/Subsidiaries - 84) - The United States (67) - Canada (1) - Europe (10) - Germany (2) - The United Kingdom (2) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) For more information visit http://www.researchandmarkets.com/research/w8...ce#summary
Plexus Shares Up 49.4% Since SmarTrend's Buy Recommendation (PLXS)
Comtex SmarTrend(R) - Fri Dec 13, 11:05AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 49.36% as of today's recent price of $39.58.
Plexus Q2 Earnings in Line, Revs Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 10:40AM CDT
Plexus reported a better-than-expected second-quarter fiscal 2014
Plexus Corp. Reports Second Quarter Results
Thomson Reuters ONE - Wed Apr 16, 3:00PM CDT
April 16, 2014
Financial Release Schedule -- Research on Abbott Laboratories, PNC, American Express, and Plexus
PR Newswire - Wed Apr 09, 9:58AM CDT
Earnings Source provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Abbott Laboratories (NYSE: ABT), The PNC Financial Services Group Inc. (NYSE: PNC), American Express Company (NYSE: AXP) and Plexus Corporation (NASDAQ: PLXS). Full earnings notes on ABT, PNC, AXP and PLXS can be downloaded upon signing up at:
Plexus Corp. Fiscal Second Quarter 2014 Earnings Date Set
Thomson Reuters ONE - Wed Mar 05, 3:00PM CST
March 5, 2014
Upgrade Alert for Plexus (PLXS)
Comtex SmarTrend(R) - Mon Feb 24, 7:09AM CST
Plexus (NASDAQ
LXS) was upgraded from Underperform to Market Perform at Raymond James today. The stock closed yesterday at $40.42 on volume of 228,000 shares, above average daily volume of 210,000. Plexus Corp. is a participant in the Electronics Manufacturing Services (EMS) Industry, providing product design,supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure,Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors. Plexus Donates Money for New Equipment at Appleton East's Tesla Engineering Charter School
Thomson Reuters ONE - Wed Feb 12, 8:30AM CST
February 12, 2014
Plexus Reports In-line Q1 Earnings; Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 8:20AM CST
Plexus reported a weak first-quarter fiscal 2014, as earnings of 61 cents per share were in line with the Zacks Consensus Estimate but revenues missed the same
Plexus Corp. Reports First Quarter Results
Thomson Reuters ONE - Wed Jan 15, 3:00PM CST
January 15, 2014
Plexus Has Returned 57.6% Since SmarTrend Recommendation (PLXS)
Comtex SmarTrend(R) - Tue Jan 14, 9:23AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ
LXS) on January 2nd, 2013 at $26.50. In approximately 13 months, Plexus has returned 57.62% as of today's recent price of $41.77. Is Plexus (PLXS) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 14, 8:30AM CST
Plexus Corp is set to report fiscal first-quarter 2014 results on Jan 15
Downgrade Alert for Plexus (PLXS)
Comtex SmarTrend(R) - Tue Jan 14, 7:00AM CST
Plexus (NASDAQ
LXS) was downgraded from Buy to Neutral at Goldman Sachs today. The stock closed yesterday at $41.64 on volume of 300,000 shares, above average daily volume of 157,000. Plexus Corp. is a participant in the Electronics Manufacturing Services (EMS) Industry, providing product design,supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure,Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors. 5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Jan 13, 12:56PM CST
These heavily shorted stocks could get squeezed much higher this week if they report positive earnings.
Form 144: Filing to Sell 89760 Shares of Fidelity Natl Information Se (FIS)
Vickers Stock Research - Tue Jan 07, 4:20AM CST
PLEXUS UPDATES FISCAL FIRST QUARTER REVENUE AND EARNINGS OUTLOOK
Plexus Up 59.6% Since SmarTrend Uptrend Call (PLXS)
Comtex SmarTrend(R) - Mon Jan 06, 4:40PM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ
LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 59.58% as of today's recent price of $42.29. Global Medical Device Manufacturing Services Outsourcing Market 2014-2018: Top 4 Dominant Players Analysed
M2 - Mon Jan 06, 11:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/3h8mj7/global_medical) has announced the addition of the "Global Medical Device Manufacturing Services Outsourcing Market 2014-2018" report to their offering. The analysts forecast the Global Medical Device Manufacturing Services Outsourcing market to grow at a CAGR of 11.86 percent over the period 2013-2018. One of the key factors contributing to this market growth is the advancement in healthcare technologies. The Global Medical Device Manufacturing Services Outsourcing market has also been witnessing the outsourcing to emerging countries. However, the stringent regulatory guidelines could pose a challenge to the growth of this market. The key vendors dominating this market space are Accellent Inc., Creganna-Tactx Medical, Greatbatch Inc., and Flextronics International Ltd. Other vendors mentioned in the report are Cadence Inc., Celestica Inc., Nortech Systems Inc., Plexus Corp., WuXiAppTec Co. Ltd., CIRTEC Medical Systems LLC, and Micro Systems Technologies Management AG. Commenting on the report, an analyst from the team said: Outsourcing of medical device manufacturing services to emerging countries is a growing trend in the market. By outsourcing, leading medical devices companies not only take advantage of reduced costs but also position themselves to better serve the local markets of emerging countries. Reduced cost of labor, a high level of technical expertise, and funding from governments for R&D investment to accelerate new product development in emerging countries such as China, India, Malaysia, Mexico, and Brazil have made them the most favored destinations for outsourcing manufacturing services. Hence, outsourcing to emerging countries is expected to drive the Global Medical Device Manufacturing Services Outsourcing market during the forecast period. Further, the report states that one of the major challenges in the market is stringent regulatory guidelines that need to be adhered to by outsourcing services providers for quality control and meet environmental requirements. For more information visit http://www.researchandmarkets.com/research/3h...al_medical About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Plexus Shares Up 61.3% Since SmarTrend's Buy Recommendation (PLXS)
Comtex SmarTrend(R) - Mon Dec 30, 9:13AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ
LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 61.32% as of today's recent price of $42.75. Plexus Up 60.4% Since SmarTrend Uptrend Call (PLXS)
Comtex SmarTrend(R) - Fri Dec 20, 4:54PM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ
LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 60.42% as of today's recent price of $42.51. Global Medical Device Outsourcing Market Report 2013
M2 - Tue Dec 17, 6:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/w8px76/medical_device#summary) has announced the addition of the "Global Medical Device Outsourcing Market Report 2013" report to their offering. "Global Medical Device Outsourcing Market Report 2013", provides insights into global markets for Medical Device Outsourcing in US$ Million by the following Device Categories: Class I, Class II, and Class III. The application areas also analyzed in the report include: - Radiology - Orthopedic - Neurology - Cardiology Another addition to this research analysis is the separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 80 companies including many key and niche players such as Accellent Inc., Advanced Scientifics Inc., Aptiv Solutions, Benchmark Electronics, Inc., Cadence, Inc, Code Refinery LLC, CregannaTactx Medical, Celestica HealthTECH, EtQ, Inc., Flextronics International, Greatbatch, Inc., HCLs Life Science, Innovative Medical Device Solutions, Intertech Engineering Associates Inc., Lake Region Medical, Memry Corporation, Millstone Medical Outsourcing, LLC, Minnetronix, Inc., Nortech Systems Inc., Plexus Corporation, Providien, RTEmd, Symmetry Medical Inc., The Tech Group, Inc., Vention Medical, Venture Manufacturing Group, Inc., and WuXiAppTec Co. Ltd. Key Topics Covered: I. Introduction, Methodology & Product Definitions - Study Reliability And Reporting Limitations - Disclaimers - Data Interpretation & Reporting Level - Quantitative Techniques & Analytics - Product Definitions And Scope Of Study - Device Category - Application Area II. Executive Summary 1. Industry Overview 2. Product Overview 3. Recent Industry Activity 4. Focus On Select Global Players 5. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 80 (including Divisions/Subsidiaries - 84) - The United States (67) - Canada (1) - Europe (10) - Germany (2) - The United Kingdom (2) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) For more information visit http://www.researchandmarkets.com/research/w8...ce#summary
Plexus Shares Up 49.4% Since SmarTrend's Buy Recommendation (PLXS)
Comtex SmarTrend(R) - Fri Dec 13, 11:05AM CST
SmarTrend identified an Uptrend for Plexus (NASDAQ
LXS) on January 2nd, 2013 at $26.50. In approximately 12 months, Plexus has returned 49.36% as of today's recent price of $39.58. 
